These findings have changed guidelines on T2D management over the last years, and GLP-1RAs are now widely used in overweight patients with T2D as well as in patients with T2D and cardiovascular disease regardless of glycaemic control
Musculoskeletal healing: A 2025 review of orthopaedic studies reported that BPC-157 accelerated recovery in tendon, ligament, muscle, and bone injuries
I probably could have gone the rest of my life without sharing that information
Among 21,822 people of European ancestry, we required participants to have complete data needed to construct the target phenotype and GWAS covariates (that is, data available for pre-treatment weight, post-treatment weight, drug type, dosage, time on treatment and factors such as age, sex and height), resulting in 18,488 participants